These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 33198923)

  • 1. Unintended Effects of GPCR-Targeted Drugs on the Cancer Phenotype.
    Cornwell AC; Feigin ME
    Trends Pharmacol Sci; 2020 Dec; 41(12):1006-1022. PubMed ID: 33198923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. G Protein-Coupled Receptors as Targets for Approved Drugs: How Many Targets and How Many Drugs?
    Sriram K; Insel PA
    Mol Pharmacol; 2018 Apr; 93(4):251-258. PubMed ID: 29298813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Established and In-trial GPCR Families in Clinical Trials: A Review for Target Selection.
    Saikia S; Bordoloi M; Sarmah R
    Curr Drug Targets; 2019; 20(5):522-539. PubMed ID: 30394207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allosteric Modulation of Class A GPCRs: Targets, Agents, and Emerging Concepts.
    Wold EA; Chen J; Cunningham KA; Zhou J
    J Med Chem; 2019 Jan; 62(1):88-127. PubMed ID: 30106578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting platelet G-protein coupled receptors (GPCRs): looking beyond conventional GPCR antagonism.
    Dowal L; Flaumenhaft R
    Curr Vasc Pharmacol; 2010 Mar; 8(2):140-54. PubMed ID: 19485898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GPCRomics: An Approach to Discover GPCR Drug Targets.
    Insel PA; Sriram K; Gorr MW; Wiley SZ; Michkov A; Salmerón C; Chinn AM
    Trends Pharmacol Sci; 2019 Jun; 40(6):378-387. PubMed ID: 31078319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variation in G-protein-coupled receptors--consequences for G-protein-coupled receptors as drug targets.
    Tang CM; Insel PA
    Expert Opin Ther Targets; 2005 Dec; 9(6):1247-65. PubMed ID: 16300474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting Gi/o protein-coupled receptor signaling blocks HER2-induced breast cancer development and enhances HER2-targeted therapy.
    Lyu C; Ye Y; Lensing MM; Wagner KU; Weigel RJ; Chen S
    JCI Insight; 2021 Sep; 6(18):. PubMed ID: 34343132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. X-ray structure breakthroughs in the GPCR transmembrane region.
    Topiol S; Sabio M
    Biochem Pharmacol; 2009 Jul; 78(1):11-20. PubMed ID: 19447219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Harnessing the genome for characterization of G-protein coupled receptors in cancer pathogenesis.
    Feigin ME
    FEBS J; 2013 Oct; 280(19):4729-38. PubMed ID: 23927072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. G protein-coupled receptors: novel targets for drug discovery in cancer.
    Lappano R; Maggiolini M
    Nat Rev Drug Discov; 2011 Jan; 10(1):47-60. PubMed ID: 21193867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GPCRs show widespread differential mRNA expression and frequent mutation and copy number variation in solid tumors.
    Sriram K; Moyung K; Corriden R; Carter H; Insel PA
    PLoS Biol; 2019 Nov; 17(11):e3000434. PubMed ID: 31765370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging concepts of guanine nucleotide-binding protein-coupled receptor (GPCR) function and implications for high throughput screening.
    Eglen RM; Bosse R; Reisine T
    Assay Drug Dev Technol; 2007 Jun; 5(3):425-51. PubMed ID: 17638542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. G protein-coupled receptors as promising cancer targets.
    Liu Y; An S; Ward R; Yang Y; Guo XX; Li W; Xu TR
    Cancer Lett; 2016 Jul; 376(2):226-39. PubMed ID: 27000991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiological impact of the adhesion G protein-coupled receptor family.
    Einspahr JM; Tilley DG
    Am J Physiol Cell Physiol; 2022 Aug; 323(2):C640-C647. PubMed ID: 35848619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small Molecule Allosteric Modulators of G-Protein-Coupled Receptors: Drug-Target Interactions.
    Lu S; Zhang J
    J Med Chem; 2019 Jan; 62(1):24-45. PubMed ID: 29457894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beyond the Ligand: Extracellular and Transcellular G Protein-Coupled Receptor Complexes in Physiology and Pharmacology.
    Dunn HA; Orlandi C; Martemyanov KA
    Pharmacol Rev; 2019 Oct; 71(4):503-519. PubMed ID: 31515243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interplay between G protein-coupled receptors and nanotechnology.
    Jiang Y; Li Y; Fu X; Wu Y; Wang R; Zhao M; Mao C; Shi S
    Acta Biomater; 2023 Oct; 169():1-18. PubMed ID: 37517621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative and systems pharmacology 2. In silico polypharmacology of G protein-coupled receptor ligands via network-based approaches.
    Wu Z; Lu W; Yu W; Wang T; Li W; Liu G; Zhang H; Pang X; Huang J; Liu M; Cheng F; Tang Y
    Pharmacol Res; 2018 Mar; 129():400-413. PubMed ID: 29133212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GPCR oligomers in pharmacology and signaling.
    González-Maeso J
    Mol Brain; 2011 May; 4(1):20. PubMed ID: 21619615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.